A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid

Clinical trial NCT05267600 · COMPLETED

Trial details

NCT number: NCT05267600
Sponsor: argenx
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Bullous Pemphigoid

Start date: 2022-06-09
Primary completion: 2024-09-13
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.